Aclaris Therapeutics Inc
Diagnostics & Research
Healthcare
ACRS
71.00 M shares
NASDAQ US
traded
07 Apr 2025
listed
no
open
1.34
52 week high
4.59
high
1.40
52 week low
1.01
previous Close
1.40
P/E ratio
market cap
194 M
div yield
0
net incoming
-7.59 M
30.95 %
net profit margin
-174.55 %
222.00 %
operating incoming
-10.47 M
16.59 %
net change in cash
24.82 M
290.80 %
cash on hand
47.65 M
108.68 %
cost of revenue
2.41 M
26.14 %
top